Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular LymphomaFrederick W. Thielen, Isaac Corro Ramos, Rob Riemsma et al.|PharmacoEconomics|2018Cited by 4